In particular, the hepatic expression of Lbp and Myd88, which functions as a direct signal of LPS, was significantly decreased in Sin A-treated mice, suggesting the importance of Sin A in the delay of NAFLD to NASH. The gene discussed is MYD88; the disease is metabolic dysfunction-associated steatotic liver disease.